Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
No Longer Available No phase listed Expanded access

A Belatacept Compassionate Use Study for Patients With a Kidney Transplant

ClinicalTrials.gov ID: NCT00719225

Public ClinicalTrials.gov record NCT00719225. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 2:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Belatacept for Renal Allograft Recipients: A Compassionate Use Program

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To make belatacept available for recipients of a renal allograft who are currently intolerant to or have contraindications to CNIs and/or m-TOR inhibitors and are either: * unable to construct an adequate immunosuppression regimen due to nonrenal toxicity / contraindication (and withdrawing the causative agent would lead to renal graft loss) OR * at imminent risk of losing the allograft kidney due to nephrotoxicity and have no other options for renal replacement therapy

Study identification

NCT ID
NCT00719225
Recruitment status
No Longer Available
Study type
Expanded access
Phase
Not listed
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Nov 22, 2021

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
7
Facility City State ZIP Site status
Scripps Green Hospital La Jolla California 92037
Office Of Dr. Allan Kirk Atlanta Georgia 30322
Acadiana Renal Physicians New Iberia Louisiana 70563
Tulane Abdominal Transplant Institute New Orleans Louisiana 70112
UNC Kidney Center Chapel Hill North Carolina 27514
The Transplant Center Of The Lehigh Valley Allentown Pennsylvania 18103
Texas Transplant Physician'S Group San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00719225, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 22, 2021 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00719225 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →